VERO logo

Venus Concept Inc. Stock Price

NasdaqCM:VERO Community·US$3.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VERO Share Price Performance

US$1.76
-1.43 (-44.79%)
US$1.76
-1.43 (-44.79%)
Price US$1.76

VERO Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk and slightly overvalued.

3 Risks
0 Rewards

Venus Concept Inc. Key Details

US$58.9m

Revenue

US$21.0m

Cost of Revenue

US$37.9m

Gross Profit

US$92.5m

Other Expenses

-US$54.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-29.38
64.36%
-92.76%
959.4%
View Full Analysis

About VERO

Founded
n/a
Employees
292
CEO
Rajiv Kanishka De Silva
WebsiteView website
www.venus.ai

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Recent VERO News & Updates

Recent updates

No updates